Citation only
via OpenAlex
Distribution of the longevity gene product, SIRT1, in developing mouse organs
Tetsuo Ogawa, Chizu Wakai, Tomomi Saito, Aya Murayama, Yuuichi Mimura, Sachiko Youfu, Tomoya Nakamachi, Makiko Kuwagata, Kazue Satoh, Seiji Shioda
Congenital Anomalies · 2010 · ▲ 29 citations
Abstract
A longevity gene product, Sir2 (silent information regulator 2) is a NAD-dependent histone deacetylase involved in longevity in yeasts, worms and flies. The mammalian homolog of Sir2, SIRT1(sirtuin 1), has been shown to play important roles related to anti-aging effects (regulating apoptosis, stress tolerance, insulin resistance, and fat metabolism). Recently, SIRT1 expression has been demonstrated to occur at as early as embryonic day 10.5 in mice. SIRT1 during developing period may be involved in the mechanism of developmental origins of adult diseases, such as diabetes and cardiovascular disease. To investigate the contribution of SIRT1, it is important to reveal the distribution of this protein during development. In the present study, we demonstrated the distribution of immunoreactivity of SIRT1 in mouse organs during prenatal and neonatal development by staining a wide variety of serial sections. The SIRT1 immunoreactivity was strongly observed in the neuroepithelial layer, dorsal root ganglion, trigeminal ganglion, eyes, roots of whiskers, and internal organs, including the testis, liver, heart, kidney, and lung during the fetal period. Neurons which had finished migrating still showed relatively strong immunoreactivity. The immunoreactivity was completely absorbed by the blocking peptide in an absorption test. During the postnatal period, the immunoreactivities in most of these organs, except the heart and testis weakened, with the liver most dramatically affected. As SIRT1 expression was demonstrated in a wide variety of developing organs, further study to investigate prenatal factors which affect SIRT1 expression and its activity is important.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/j.1741-4520.2010.00304.x
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
Ogawa, T., Wakai, C., Saito, T., Murayama, A., Mimura, Y., Youfu, S., Nakamachi, T., Kuwagata, M., Satoh, K., & Shioda, S. (2010). Distribution of the longevity gene product, SIRT1, in developing mouse organs. <em>Congenital Anomalies</em>. https://doi.org/10.1111/j.1741-4520.2010.00304.x
Vancouver
Ogawa T, Wakai C, Saito T, Murayama A, Mimura Y, Youfu S, et al. Distribution of the longevity gene product, SIRT1, in developing mouse organs. Congenital Anomalies. 2010. doi:10.1111/j.1741-4520.2010.00304.x.
BibTeX
@article{tetsuo2010Distri,
title = {Distribution of the longevity gene product, SIRT1, in developing mouse organs},
author = {Tetsuo Ogawa and Chizu Wakai and Tomomi Saito and Aya Murayama and Yuuichi Mimura and Sachiko Youfu and Tomoya Nakamachi and Makiko Kuwagata and Kazue Satoh and Seiji Shioda},
journal = {Congenital Anomalies},
year = {2010},
doi = {10.1111/j.1741-4520.2010.00304.x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell 2008
Open access · OA
SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during Aging
Molecular Medicine Reports 2012
Open access · OA
Maternal protein restriction in rats leads to reduced PGC-1α expression via altered DNA methylation in skeletal muscle
Experimental Gerontology 2000
Citation only
Targeted neuronal gene expression and longevity in Drosophila
Nature Reviews Disease Primers 2019
Open access · OA
Diabetic neuropathy
Current Drug Targets 2013
Citation only
Sirtuins as Possible Drug Targets in Type 2 Diabetes
Disease Models & Mechanisms 2010
Open access · OA